论文部分内容阅读
目的观察通心络联合厄贝沙坦对肺心病心力衰竭的治疗效果。方法 54例肺心病心力衰竭患者,随机分成两组:治疗组及对照组。对照组:常规治疗;治疗组:常规治疗基础上加用通心络胶囊联合厄贝沙坦,观察两组临床症状及心功能改善情况、右室直径及肺动脉收缩压变化。结果两组患者治疗后临床症状、心功能改善、右室直径及肺动脉收缩压变化差异有统计学意义(P<0.05)。结论通心络联合厄贝沙坦对肺心病心衰患者有明显的疗效,无明显不良反应发生。
Objective To observe the therapeutic effect of Tongxinluo combined with irbesartan on heart failure of pulmonary heart disease. Methods 54 cases of heart failure patients with cor pulmonale were randomly divided into two groups: treatment group and control group. Control group: conventional treatment; treatment group: Based on routine treatment plus Tongxinluo capsule combined with irbesartan, clinical symptoms and improvement of cardiac function, right ventricular diameter and pulmonary artery systolic pressure were observed. Results After treatment, clinical symptoms, cardiac function, right ventricular diameter and pulmonary artery systolic pressure were significantly different between the two groups (P <0.05). Conclusion Tongxinluo combined with irbesartan in patients with heart failure of pulmonary heart disease have a significant effect, no significant adverse reactions.